Related Articles
Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer
Role of histone deacetylase inhibitors in the treatment of cancer (Review)
Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells
Histone deacetylase 6 inhibition in urothelial cancer as a potential new strategy for cancer treatment
OBP‑801, a novel histone deacetylase inhibitor, induces M‑phase arrest and apoptosis in rhabdomyosarcoma cells